Intensive chemotherapy (IC) combination with second- or third-generation TKI improves survival compared to non-IC with first-generation TKI. Allo-HCT was suggestive of improving RFS/OS after propensity score matching and multivariable analysis.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/ajh.27475 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!